| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $210.3M | -7.8% | -1.7% |
| Cost of Revenue | $167.5M | -6.4% | -1.1% |
| R&D Expense | $14.5M | -22.7% | -18.1% |
| SG&A Expense | $31.6M | -3.8% | +19.1% |
| Operating Income | -$3.3M | -26.1% | -1141.0% |
| Pre-tax Income | -$9.7M | -6.6% | -165.6% |
| Income Tax | -$343K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.0M | +8.5% | -0.3% |
| Accounts Receivable | $153.1M | -6.2% | -3.4% |
| Inventory | $145.4M | +0.7% | -17.6% |
| Current Assets | $384.3M | -2.3% | -7.3% |
| Total Assets | $632.1M | -1.1% | -4.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $25.2M | — | — |
| Investing Cash Flow | -$15.6M | — | — |
| Financing Cash Flow | -$34.6M | — | — |
| -240.6% |
| -110.0% |
| Net Income | -$9.4M | -0.1% | -32.5% |
| EPS (Basic) | -$0.34 | +0.0% | -30.8% |
| EPS (Diluted) | -$0.34 | +0.0% | -30.8% |
| $180.0M |
| -2.2% |
| +6.0% |
| Long-term Debt | $0 | — | — |
| Stockholders' Equity | $251.2M | -3.6% | -7.4% |